Mike Morneau
Vice President, Finance and Administration at Viking Therapeutics, Inc. - San Diego, CA, US
Mike Morneau's Colleagues at Viking Therapeutics, Inc.
Mike Morneau's Contact Details
858-704-4660
Amecameca, México, Mexico
Viking Therapeutics, Inc.
Mike Morneau's Company Details
Viking Therapeutics, Inc. (Nasdaq:VKTX) is a clinical-stage company focused on the development of first-in-class or best-in-class therapies for metabolic and endocrine disorders. Our most advanced candidate is a non-steroidal selective androgen receptor modulator (SARM) currently in Phase 2 trial for the treatment recovery from hip fracture surgery. Our thyroid receptor beta (TRb) agonist platform, also in Phase 2, is being developed for lipid disorders such as hypercholesterolemia and fatty liver diseases such as non-alcoholic steatohepatitis (NASH) as well as for rare diseases of glycogen storage disease (GSD 1a) and X-linked adrenoleukodystrophy, or X-ALD. See more at http://www.vikingtherapeutics.com